Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Trupanion Inc.

Start price
Target price
Perf. (%)
€21.20
19.02.24
-
19.02.25
35.28%
12.07.24

Risky Investment
Theravet S.a.

Start price
Target price
Perf. (%)
€1.04
19.02.24
-
19.02.25
-65.87%
11.07.24

Probably not worthwhile Investment
Little innovation
buy
2CRSI S.A.

Start price
Target price
Perf. (%)
€5.14
19.02.24
-
19.02.25
-25.49%
11.07.24

Could be worthwhile Investment >10% per year
buy
Deutsche Telekom AG

Start price
Target price
Perf. (%)
€22.27
19.02.24
€23.30
19.02.25
10.78%
12.07.24

Unipol Gruppo Finanziario SpA

Start price
Target price
Perf. (%)
€6.76
19.02.24
-
19.02.25
43.65%
12.07.24

Risky Investment
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€12.05
18.02.24
€13.50
31.08.24
31.54%
12.07.24

Liqtech International Inc.

Start price
Target price
Perf. (%)
€2.83
18.02.24
-
18.02.25
-
09.02.24

Comstock Mining Inc.

Start price
Target price
Perf. (%)
€0.42
18.02.24
-
18.02.25
-68.81%
10.07.24

buy
LiveRamp Holdings, Inc.

Start price
Target price
Perf. (%)
€33.80
18.02.24
-
18.02.25
-15.98%
09.07.24

AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€1.65
18.02.24
-
18.02.25
11.85%
02.05.24

buy
CSI Compressco L.P.

Start price
Target price
Perf. (%)
€0.51
18.02.24
-
18.02.25
-
14.04.20

Rubicon Technology

Start price
Target price
Perf. (%)
€0.64
18.02.24
-
18.02.25
-4.72%
11.07.24

Trevena Inc.

Start price
Target price
Perf. (%)
€0.51
18.02.24
-
18.02.25
-59.31%
11.07.24

China Sxt Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.98
18.02.24
-
18.02.25
-39.70%
12.07.24

High valuation
Bad rating
Lower EBIT Margin than peer group
Low dividend yield expected
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.10
18.02.24
-
18.02.25
-31.82%
11.07.24

Probably not worthwhile Investment
Bad rating
High valuation
Low dividend yield expected
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.70
18.02.24
-
18.02.25
-47.29%
18.06.24

buy
Alphabet Inc. C

Start price
Target price
Perf. (%)
€131.38
18.02.24
€150.00
18.02.25
30.50%
12.07.24

buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.70
18.02.24
-
18.02.25
-47.29%
18.06.24

Cardiol Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.31
18.02.24
-
18.02.25
47.33%
12.07.24

Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.22
18.02.24
-
18.02.25
-27.52%
11.07.24

Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.52
18.02.24
-
18.02.25
-42.92%
12.07.24

Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€7.19
18.02.24
-
18.02.25
3.62%
12.07.24

Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.10
18.02.24
-
18.02.25
-31.82%
11.07.24

buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
18.02.24
€4.00
31.01.26
-14.45%
11.07.24

Could be very worthwhile Investment >20% year
buy
Be Semiconductor Inds N.v.

Start price
Target price
Perf. (%)
€160.00
18.02.24
-
18.02.25
3.83%
11.07.24